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Abstract Low bone mineral density (BMD) is a risk
factor for osteoporotic fracture with a high heritability.
Previous large scale linkage study in Northern Chinese has
identiﬁed four signiﬁcant quantitative trait loci (QTL) for
BMD variation on chromosome 2q24, 5q21, 7p21 and
13q21. We performed a replication study of these four QTL
in 1,459 Southern Chinese from 306 pedigrees. Successful
replication was observed on chromosome 5q21 for femoral
neck BMD with a LOD score of 1.38 (nominal
p value = 0.006). We have previously identiﬁed this locus
in a genome scan meta-analysis of BMD variation in a
white population. Subsequent QTL-wide gene-based asso-
ciation analysis in 800 subjects with extreme BMD iden-
tiﬁed CAST and ERAP1 as novel BMD candidate genes
(empirical p value of 0.032 and 0.014, respectively). The
associations were independently replicated in a Northern
European population (empirical p value of 0.01 and 0.004
for CAST and ERAP1, respectively). These ﬁndings
provide further evidence that 5q21 is a BMD QTL, and
CAST and ERAP1 may be associated with femoral neck
BMD variation.
Introduction
Family-based linkage analysis has successfully identiﬁed
genes that contribute to relatively rare disorders with
monogenic patterns of inheritance. In contrast, efforts to
extend this family-based approach to common disorders
and quantitative traits have been less successful. It is often
particularly difﬁcult to identify the causal variant under the
quantitative trait loci (QTL). Linkage analysis is based on
the principle of identiﬁcation by decent (Cheung et al.
2010) to test the co-segregation of a genetic marker
(e.g., microsatellite marker) and the trait-of-interest. The
co-segregated genomic loci can also be very large, and
multiple disease genes may be present under the QTL. In
addition, although there may be only one disease gene in
the QTL, the linkage signal may be elicited by multiple
causal variants in the disease gene and in different families.
The presence of allelic heterogeneity thus limits the ability
to identify the causal variant using a SNP association
approach.
To date, more than ﬁfteen genome-wide linkage scans
for bone mineral density (BMD) have been performed in
study populations of different ethnicity, of which two were
Chinese. Niu et al. (1999) determined that 2p21 and 13q34
are modestly linked to forearm BMD in a genome-wide
linkage scan conducted in 218 individuals from Anqing
district. Hsu et al. (2007) observed signiﬁcant evidence of
linkage at 2q24 for total hip, 7p21 for femoral neck and
5q21 for combined BMD in 3,093 siblings from Anhui, and
13q21 for lumbar spine BMD in women in the same study
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DOI 10.1007/s00439-011-0972-2population. With reported genetic heterogeneity between
Northern and Southern Chinese, it is not known if these
quantitative trait loci (QTL) are associated with BMD
variation in Southern Chinese. In addition, the QTL genes
have not been identiﬁed.
Independent replication of linkage is a fundamental
prerequisite for the commencement of positional cloning
studies, in order to reduce the possibility of false positive
initial ﬁnding. It is believed that some genes associated
with BMD are likely to be site-speciﬁc and sex-speciﬁc; we
therefore performed linkage analysis using high density
microsatellite markers to investigate the linkage between
four QTLs reported by Hsu et al. (2007) in a sample of
1,459 individuals from 306 Southern Chinese families of
probands with low BMD. Subsequent gene-based associa-
tion study was performed to identify potential QTL genes
underlying the linkage peak.
Methods and materials
Subjects for linkage and association analyses
Subjects for the current study were drawn from an
expanding database of more than 8,000 subjects at the
Osteoporosis Centre, Queen Mary Hospital, Hong Kong.
Subject recruitment has been ongoing since 1998 with
individuals drawn from road shows and health talks on
osteoporosis. Study subjects gave informed written consent
and were invited to the Centre for bone mineral density
measurement and physical examination. They were also
interviewed by a trained research assistant using a struc-
tured questionnaire to obtain data on ethnicity, social,
medical and reproductive history, dietary and lifestyle
factors, and family history of osteoporosis. Families with a
proband with BMD Z-score B- 1.28 (which is equivalent
to the lowest 10% of the population) at either the lumbar
spine or hip were identiﬁed. Individuals with a previous or
family history of disease known to affect bone metabolism,
premature menopause (age \40), bilateral oophorectomy
or drug use that could affect bone turnover and BMD were
excluded from study. All study subjects were of Southern
Chinese Han descent. Based on the previous estimates of
the heritability of BMD (Ng et al. 2006) and the relative
informativeness of the 1,021 pedigrees in our cohort
(Cheung et al. 2008), 306 families were selected for the
current study.
In the association study of QTL genes, 800 unrelated
Hong Kong Southern Chinese (HKSC) women with
extremely high (n = 376) or low BMD (n = 424) were
selected from the same database as mentioned above. This
study aimed to identify genetic factors that affect BMD
variation in women. We adopted a threshold deﬁned case–
control study design. Subjects with BMD Z-score B- 1.28
at either the lumbar spine (LS) or femoral neck (FN) (the
lowest 10% of the total population) were categorized as
low-BMD subjects. High-BMD subjects comprised indi-
viduals with BMD Z-score C? 1.0 at either site (which is
equivalent to the highest 15% of the total population).
These selection criteria captured the extreme 25% BMD
information of the total population. Subjects who reported
the presence of disease or environmental factors that may
affect BMD and bone metabolism were excluded from
study. The recruitment procedure and exclusion criteria
have been detailed elsewhere (Cheung et al. 2008) but the
latter included the following: a history of chronic medical
illness, premature menopause age below 40 years, malab-
sorption, previous major gastrointestinal surgery, metabolic
bone disease, endocrine disorders including hyper- and
hypothyroidism, or prescription of medication that may
affect bone and calcium metabolism, hormone replacement
therapy, anti-osteoporosis medication, and active vitamin
D3 metabolites. The 800 studied subjects selected for the
association study did not overlap with the pedigrees for
linkage analysis.
Measurement
BMD (g/cm
2) at the lumbar spine (L1–L4), femoral neck
(FN), trochanter and total hip was measured using dual-
energy X-ray absorptiometry (DEXA, Hologic QDR 2000
plus, Hologic, Waltham, MA, USA). The in vivo precision
of the machine for lumbar spine, FN and total hip region
was 1.2, 1.5 and 1.5%, respectively.
Microsatellite and SNP genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes of the subjects using a standard phenol/chloroform
method. Nineteen selected microsatellite markers (Table 3)
in close proximity to the four loci reported by Hsu et al.
(2007) were selected using the marker order and map
positions obtained from the Marshﬁeld electronic database
(http://www.research.marshﬁeldclinic.org/genetics/Marker
Search/searchMarkers.asp). Fluorescently labeled PCR
primers (ABI) were used to amplify the selected micro-
satellite loci. Electrophoresis and size determination of the
ampliﬁed DNA fragments were performed using a Genetic
Analyzer 3700 (ABI) and GENESCAN (ABI), respec-
tively. Control DNA CEPH 1347-02 was used to monitor
PCR ampliﬁcation efﬁciency and control for gel-to-gel
variation.
For the gene-based association study, subjects were
genotyped via the Inﬁnium assay (Illumina, San Diego,
CA, USA) with Human610-quad chip including 564,214
SNPs. PLINK (version 1.04) used for data management
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123and quality control statistics. After exclusion of individuals
based on strict quality-control criteria, 785 individuals and
488,853 SNPs were retained for analysis. Subjects were
excluded according to the following criteria: (1) genotyp-
ing call rate less than 95% (n = 5); (2) autosomal hetero-
zygosity \27 or [31% (the same ﬁve subjects with low
genotyping call rate); (3) related or identical to other
individuals in the sample (n = 7); and (4) discordance of
observed gender and estimated sex (n = 3). SNPs were
excluded if: (1) genotyping call rate was B95% (1,158
SNPs), (2) Hardy–Weinberg equilibrium (HWE) p value
\1.0 9 10
-4 (904 SNPs), and (3) minor allele frequency
(MAF)\0.01 (73,589 SNPs). The average genotyping call
rate of retained SNPs was 99.91%.
Linkage analysis and gene-based association study
Genotype inconsistencies were identiﬁed using Pedstats
(Wigginton and Abecasis 2005) and linkage analysis con-
ducted using Merlin-regress (Sham et al. 2002). To control
for gender and age effects, a multi-point analysis was
performed at 0.5 cM grid of equal-space locations for
BMD Z-scores at the lumbar spine, femoral neck, tro-
chanter and total hip in the whole population and all sub-
groups. Sub-group analysis was performed by setting trait
values for the uninterested subgroups as missing. A sex-
averaged genetic map was adopted for the whole-sample
analysis and a sex-speciﬁc map was applied for sub-group
analysis. A heritability estimate of 0.7 was employed based
on our previous heritability study of BMD at the spine and
hip (Ng et al. 2006). A nominal p value of 0.01 is required
to declare successful replication of a previously reported
linkage signal (Lander and Kruglyak 1995).
For the gene-based association study, QTL with a
nominal p value \0.01 were selected for regional gene-
based association study. Candidate genes located within the
QTL were included in the analysis. We ﬁrst obtained a
standardized residual of BMD with adjustment of age and
weight, since height was not signiﬁcantly associated with
BMD in our cohort. This standardized residual of BMD
was normally distributed (Kolmogorov–Smirnov test
p value[0.05). The association p value was obtained using
PLINK (version 1.04) with the linear regression model
testing the association between standardized residual of
BMD with each SNP. For each SNP, the asymptotic
p value for the relationship between the number of minor
alleles and BMD was derived from a two-sided t statistic
assuming the minor allele had an additive effect. The
association p values were used to calculate gene-based test
statistics of each gene (n = 18). The empirical p value was
calculated as the proportion of simulated test statistics
(using Monte Carlo approach) that exceeded the observed
gene-based test statistic. In silico replication in 5,858
European subjects was performed using the p value
obtained from a recent meta-analysis of GWAS of BMD
(Styrkarsdottir et al. 2008). Gene-based analysis in each
population was performed using VEGAS (Liu et al. 2010).
The brief description of VEGAS is provided in supple-
mentary information.
In silico gene expression study
In order to study whether the candidate genes are regulated
by osteogenic molecule (bmp2) in murine MC3T3-1b pre-
osteoblast cell line, we performed in silico gene expression
study by retrieving the normalized microarray data
[Accession number: GDS679) (Zamurovic et al. 2004)]
from GEO database. Two datasets were compared, one was
grown under the stimulation by bmp2 for 1 day, and the
control was grown without stimulation of bmp2. The dif-
ferences in total RNA expression in MC3T3-1b cells with
and without stimulation by bmp2 and ascorbic acid were
calculated using an independent t test.
Results
Clinical characteristics of the subjects for linkage and
association studies are described in Tables 1 and 2,
respectively. Brieﬂy, there were 306 Mendelian-consistent
pedigrees, with 1,166 females and 293 males. The average
size and number of generations of these pedigrees was 6.46
and 2.33, respectively. The overall drop-out rate of
microsatellite markers was 3.65%. These genotypes were
discarded due to either low intensity of the ampliﬁed PCR
product or Mendelian inconsistency. The average hetero-
zygosity of these markers was 0.777. Details of the 19
markers included in this study are shown in Table 3.
In the whole-sample analysis, a multi-point maximum
LOD score (MLS) of 1.383 (nominal p = 0.006) was
detected at 107.26 cM on 5q21-22 for femoral neck BMD
(Fig. 1). Sub-group analysis was also performed, but no
LOD score exceeded one. For other QTL, no region had
LOD score exceeding one.
QTL on chromosome 5q with a nominal p value B0.01
were deﬁned between 104.76 and 112.26 cM, equivalent to
physical position 95,738,450–104,090,852 (hg 18) approx-
imately. A total of 18 genes were annotated in this region:
PCSK1, CAST, ERAP1, ERAP2, LNPEP, LIX1, RIOK2,
RGMB, CHD1, FAM174A, ST8SIA4, SLCO4C1, SLCO6A1,
PAM, GIN1, HISPPD1, C5orf30 and NUDT12. To identify
a BMD gene(s) responsible for the QTL on chromosome
5p21-22 in Hong Kong Southern Chinese, we conducted a
gene-based statistical analysis for femoral neck BMD on
800 unrelated individuals with extreme BMD using geno-
types from 910 heterozygous SNPs (as deﬁned by MAF
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123[0.01) that were available in the Illumina Human 610 quad
chip. Association analysis was restricted to femoral neck
BMD, because the signiﬁcant replication of linkage was
observed only in femoral neck BMD. A linear regression
model was used to calculate the SNP-based p value. Fifty-
nine SNPs showed a higher than expected nominal p value
of 0.05. Table 4 shows the results of gene-based association
test of 18 genes with femoral neck BMD. Among the 18
genes, 2 genes CAST and ERAP1 showed empirical p value
\0.05 after 100,000 rounds of simulation.
We then performed in silico replication using the data
from 5,858 Northern European subjects to independently
substantiate these gene-based association results in a sep-
arate ethnic population. Interestingly, these two genes also
showed signiﬁcant associations with femoral neck BMD
with empirical p values \0.05. Meta-analysis using a
weighted z-transformed test revealed a more signiﬁcant
p value of 0.019 and 0.007 for CAST and ERAP1, respec-
tively (Table 5). To provide preliminary insight of the roles
of CAST and ERAP1 in osteoblast, we retrieved the nor-
malized expression data of CAST from the GEO dataset
record GDS679. We observed that in the presence of
BMP2 and ascorbic acid, CAST expression was signiﬁ-
cantly decreased by 37% when compared with control
(without stimulation of ascorbic acid and bmp2) with a
p value of 0.001. Since ERAP1 was not included in the
microarray, no analysis was done.
Discussion
In this study, we replicated a previously reported linkage
peak on 5q21-22 for femoral neck BMD (p = 0.006) in
Hong Kong Southern Chinese and subsequently identiﬁed
two BMD genes, CAST and ERAP1, using a gene-based
association approach in HKSC and Northern European
populations. Our bioinformatics analysis suggested that
CAST is regulated by BMP in osteoblasts. In our previous
meta-analysis of genome-wide scans in Caucasians, a
broad region on chromosome 5 (5q14.3-q23.2) was iden-
tiﬁed as a femoral neck BMD QTL (Ioannidis et al. 2007).
This bin nonetheless ﬂanks more than 4 Mb in the genome
and poses problems in identiﬁcation of the QTL gene.
Thus, this study is vital since it solved many of the
Table 1 Demographic
information of 1,459 individuals
from 306 multi-generation
pedigrees
Subject Total (n = 1,459) Male (n = 293) Female (n = 1,166)
Age (years) 47.4 ± 15.3 49 ± 16 47 ± 15.1
Height (cm) 157.8 ± 0.08 167.8 ± 0.06 155.2 ± 0.64
Weight (kg) 56.2 ± 10.4 66.3 ± 9.9 53.6 ± 8.9
Post-menopausal women (N) 485 (33.2%) NA 485 (41.6%)
Spine BMD (g/cm
2) 0.902 ± 0.168 0.921 ± 0.149 0.897 ± 0.172
Femoral neck BMD (g/cm
2) 0.697 ± 0.129 0.720 ± 0.125 0.691 ± 0.130
Trochanter BMD (g/cm
2) 0.604 ± 0.121 0.644 ± 0.113 0.594 ± 0.121
Total hip BMD (g/cm
2) 0.797 ± 0.143 0.856 ± 0.136 0.782 ± 0.140
Spine Z-score -0.33 ± 1.18 -0.33 ± 1.18 -0.33 ± 1.18
Femoral neck Z-score -0.32 ± 1.04 -0.33 ± 0.80 -0.32 ± 1.09
Trochanter Z-score -0.26 ± 1.11 -0.22 ± 0.93 -0.27 ± 1.15
Total Hip Z-score -0.30 ± 1.15 -0.19 ± 0.95 -0.32 ± 1.20
Spine T-score -0.80 ± 1.33 -0.55 ± 1.17 -0.86 ± 1.36
Femoral neck T-score -0.85 ± 1.19 -0.76 ± 0.86 -0.86 ± 1.26
Trochanter T-score -0.71 ± 1.25 -0.55 ± 0.95 -0.75 ± 1.32
Total hip T-score -0.72 ± 1.30 -0.61 ± 0.96 -0.75 ± 1.37
Table 2 Demographic information of 800 unrelated individuals with
extreme BMD
Group High BMD Low BMD
Number 376 424
Age (years) 46.6 ± 14.8 51.1 ± 15.9
Height (m) 1.58 ± 0.06 1.53 ± 0.07
Weight (kg) 61.1 ± 9.9 49.1 ± 6.7
Post-menopausal women (N) 131 (34.8%) 270 (63.7%)
BMD Z-score
Lumbar spine 1.05 ± 0.78 -1.59 ± 0.53
Femoral neck 1.15 ± 0.79 -1.36 ± 0.60
Data are expressed as mean ± standard deviation. The 800 subjects
with extreme BMD phenotype were selected from a growing database
of Hong Kong Southern Chinese (more than 7,000 volunteers). The
low BMD subjects are deﬁned as an individual having BMD
Z-score B- 1.28 at either lumbar spine (LS) or femoral neck (FN),
which belongs to the lowest 10% of the total cohort, while high BMD
subjects are individuals with BMD Z-score C? 1.0 at either of the
two skeletal sites
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HKSC, suggesting that this BMD QTL is important in
determining BMD in multiple ethnicity groups. Second, the
linkage signal was only observed for femoral neck BMD,
not for other skeletal sites, providing further evidence that
this QTL is speciﬁc for femoral neck BMD determination.
Table 3 The chromosomal
position, heterozygosity and
average inter-marker distance of
the 19 selected microsatellite
markers
Chromosome Region Marker Sex-averaged
position (cM)
Heterozygosity Average inter-marker
distance (cM)
2 2q24.3 D2S2330 169.41 0.82 6.18
2q31.1 D2S335 175.91 0.80
2q31.1 D2S2188 180.79 0.64
2q32.1 D2S364 186.21 0.80
2q32.3 D2S117 194.45 0.82
5 5q21.1 D5S644 104.76 0.85 4.91
5q21.1 D5S495 108.07 0.80
5q21.3 D5S433 111.97 0.85
5q22.2 D5S2027 119.5 0.78
7 7p21.3 D7S2464 17.74 0.68 3.67
7p21.2 D7S664 20.84 0.71
7p21.1 D7S2557 23.29 0.73
7p21.1 D7S507 28.74 0.89
13 13q12.3 D13S219 28.87 0.66 5.40
13q13.1 D13S218 32.9 0.65
13q13.2 D13S263 38.32 0.85
13q14.2 D13S153 45.55 0.82
13q21.31 D13S1320 49.38 0.76
13q22.1 D13S156 55.85 0.80
Fig. 1 Multi-point LOD scores for linkage of BMD at lumbar spine, femoral neck, trochanter and total hip at (a) 2q24-32, (b) 5q21-22, (c) 7p21
and (d) 13q12-22
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123Third, we ﬁne mapped the QTL to less than 1 Mb region
using high density microsatellite markers. Fourth, the two
BMD genes initially identiﬁed in HKSC were subsequently
in silico replicated in Northern Europeans suggesting these
genes affect BMD in both populations. This is in accor-
dance with our observations in the previous meta-analysis
and the current linkage result.
Among the four QTL studied, we observed signiﬁcant
replication only on chromosome 5, and were unable to
replicate other ﬁndings by Hsu et al. (2007) of the signif-
icant QTL on chromosome 2 (2q24), 7 (7p21) and 13
(13q21). Indeed, at these chromosomal locations, our peak
LOD scores were less\1 (Fig. 1). This lack of replication
in genetic loci between the two studies may be due to
several factors. As with other complex disease genetic
studies, power to localize QTL may be limited and result in
between-study discrepancies. In addition, genetic factors
vary across different ethnicities. The study by Hsu et al.
(2007) focused on a Northern Chinese population, whereas
our study examined Southern Chinese as the genetic
backgrounds of different populations in different Chinese
geographical areas that are known to differ (Xu et al.
2009). If relatively rare variants are involved in the
determination of BMD variation, we may expect consid-
erable differences in the localization of the most important
genetic loci across different populations or within the same
population at different geographic locations. Linkage
studies of such complex traits cannot exclude the possi-
bility of the presence of genetic regions for important
QTLs. Thus, the lack of concordance cannot be interpreted
as evidence to dispute the hypothesis that a QTL exists in a
particular genomic region. Although linkage of BMD to
7p21 was not detected in the current study, linkage to
7p15-13, a well-replicated QTL in Caucasians, was con-
ﬁrmed in the same Southern Chinese family cohort. In the
whole-sample analysis, evidence suggestive of linkage of
total hip BMD to 7p14 (MLS = 2.75, nominal
p = 0.0002) was observed (Li et al. 2010). In fact, the loci
7p15-13 is located just beside 7p21. The differences
observed between our Southern Chinese population and the
Anhui sample (Hsu et al. 2007) may be attributed to the
population substructure of Han Chinese (Xu et al. 2009).
Results from the linkage of femoral neck BMD detected
a signiﬁcant replication of QTL on chromosome 5q22-23
Table 4 Gene-based association study of 18 genes located with QTL on 5q21-22 in HKSC
Gene Start Stop No. of SNPs No. of simulations Test Gene P Best SNP SNP P
PCSK1 95,751,874 95,794,708 5 1,000 1.463201 0.823 rs6860611 0.490
CAST 96,023,696 96,136,141 67 100,000 141.1646 0.034 0.0002
ERAP1 96,122,269 96,169,648 42 100,000 114.8847 0.024 rs13160562 0.0002
ERAP2 96,237,399 96,281,162 21 1,000 13.2657 0.624 rs2927612 0.040
LNPEP 96,297,101 96,390,871 18 1,000 1.771527 0.996 rs2303138 0.611
LIX1 96,453,329 96,504,276 29 1,000 10.34403 0.926 rs4869151 0.148
RIOK2 96,524,396 96,544,700 24 1,000 12.31268 0.823 rs4869151 0.148
RGMB 98,132,899 98,160,098 16 1,000 10.62398 0.608 rs12652843 0.047
CHD1 98,218,807 98,290,138 16 1,000 12.15287 0.525 rs9327919 0.036
FAM174A 99,899,022 99,950,339 15 1,000 6.197312 0.808 rs247938 0.150
ST8SIA4 100,170,802 100,266,869 17 1,000 12.09712 0.521 rs4703116 0.179
SLCO4C1 101,597,590 101,660,152 37 1,000 45.63731 0.259 rs10479200 0.004
SLCO6A1 101,735,550 101,862,619 37 1,000 26.08828 0.542 rs10479200 0.004
PAM 102,229,425 102,393,316 29 1,000 17.7014 0.649 rs467693 0.094
GIN1 102,449,602 102,483,741 4 1,000 3.431025 0.430 rs26521 0.073
HISPPD1 102,493,155 102,566,808 8 1,000 3.539095 0.573 rs26521 0.073
C5orf30 102,622,340 102,642,260 9 1,000 1.094518 0.972 rs187580 0.608
NUDT12 102,912,454 102,926,389 29 1,000 16.2771 0.831 rs861085 0.130
Gene-based p value\0.05 are bolded
Table 5 Replication and meta-analysis of CAST and ERAP1 in 5,858 Northern European subjects
Gene No. of SNPs No. of simulations Test Gene P Best SNP SNP P Meta-P
a Q stats Phetero
CAST 48 100,000 95.53 0.032 rs42398 0.010 0.019 417.42 \0.001
ERAP1 31 100,000 87.42 0.014 rs845028 0.004 0.007 756.00 \0.001
a Meta-analysis was done using weighted Z-transformed test
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123in HKSC participants. Further investigation of 18 genes
within this region with p value B0.01 demonstrated genetic
associations with two genes CAST and ERAP1. Notably,
rs13160562 that showed the most signiﬁcant p value was
associated with these two genes as rs13160562 was located
within 50 kb upstream and downstream region of these two
gene loci. The femoral neck BMD Z-score for each geno-
type of rs13160562 is provided in Supplementary Figure 1.
rs13160562 is located upstream of the gene CAST, but
within the gene locus of ERAP1. Nonetheless, functional
study is required to conﬁrm whether this SNP affects CAST
or ERAP1 or both. In silico replication study in Northern
Europeans and the meta-analysis suggested that both genes
may be important for BMD variation, although the p values
of heterogeneity indicate the need for cautious interpreta-
tion. Nevertheless, to further support this observation, we
used RNA expression data (Zamurovic et al. 2004) from
the MC3T3-1B cell and found that there was a signiﬁcant
decrease in CAST mRNA expression upon stimulation of
BMP2. These data suggest that CAST may be a negative
modulator of BMD and a downstream target of BMP2 in
modulating CAST mRNA expression of osteoblasts. This
observation is in line with a study that suggested that cal-
pain–calpastatin system is essential for osteoblast prolif-
eration and differentiation although the system is regulated
by BMP (Murray et al. 1997). CAST encodes for calpast-
atin, which is an endogenous calpain inhibitor. In MC3T3
preosteoblast cell line, calpastatin inhibits calpains and
mediates the PTH-stimulated cAMP accumulation, sug-
gesting calpastatin is involved in PTH signaling pathway
and bone metabolism (Shimada et al. 2005). ERAP1
encodes for endoplasmic reticulum aminopeptidase 1,
which is a member of the M1 family of zinc metallopep-
tidases. It regulates MHC class I antigen presentation
(York et al. 2002) and associated with autoimmune dis-
eases, such as psoriasis (Sun et al. 2010) and ankylosing
spondylitis (Chen et al. 2011), in the recent GWA meta-
analyses. However, ERAP1 transcript was not noticed in
the microarray data, thus it remains to be determined
whether ERAP1 is functional in osteoblast proliferation and
differentiation.
Since 2007, a number of genome wide association
studies for BMD variation have been published (Rivad-
eneira et al. 2009; Styrkarsdottir et al. 2008, 2009) with a
number of well-known candidate genes and novel candi-
date genes conﬁrmed or identiﬁed. Nevertheless, none of
the genes suggested by the current study reached genome-
wide signiﬁcant level in these studies. This is not surprising
as the ultraconservative Bonferroni correction inﬂates the
false-negative rate (Cheung et al. 2010). Statistical power
may also be further reduced by allelic heterogeneity in
different ethnic groups although gene-based association
study is an approach little inﬂuenced by allelic
heterogeneity (Cheung et al. 2008). As such, this study had
a number of advantages: ﬁrst, we used family-based
genetic data and successfully replicated and localized a
common BMD QTL that has been implicated in Northern
Chinese and meta-analysis in a relatively small genetic
region. This is particularly important as the number of
genes tested was reduced by the linkage analysis with high
density microsatellite markers. Additionally, QTL-wide
gene-based association study and meta-analysis identiﬁed
two novel potential BMD genes in Southern Chinese and
Northern Europeans. The function of one of these genes,
CAST, in bone metabolism was further supported by an
mRNA expression study suggesting this gene is a negative
modulator of osteoblast differentiation. The current study
involved the combined use of linkage, genetic association
analysis and RNA expression data to account for potential
variation within a given phenotype. Successful genetic
association studies result in the localization of a gene or
genetic region involved with the phenotype being investi-
gated. Thus, various sources of independent data can be
used to augment evidence for the involvement of a par-
ticular gene and improve assumptions regarding causal
associations. There were nonetheless some limitations in
this study. Our linkage cohort had sufﬁcient power to
detect QTL with large effect size, but not QTL with small
effect size (Cheung et al. 2006; Huang et al. 2006). We
only have replication data from the European population,
despite the fact that the sample size is large. Moreover, a
signiﬁcant genetic heterogeneity was detected between two
studies. The genetic heterogeneity could be contributed by
the difference in study design, such as inclusion of both
men and women in the Northern European study, but only
women in the Southern Chinese study; random cohort
design in the Northern European, but threshold deﬁned
case–control design in the Southern Chinese study. The
p values of CAST and ERAP1 obtained in HKSC study did
not pass Bonferroni correction, and the association signals
are relatively marginal in all analyses. Successful in silico
replication in Northern European and in silico expression
analysis suggested that these two genes are less likely to be
spurious ﬁndings although cautious interpretation is nee-
ded. Future replications and/or functional analysis will be
required to examine the effect of these two genes on bone
metabolism. In addition, this study could not conﬁrm
whether CAST or ERAP1 are the QTL genes in the pedi-
grees, since the association study was performed in a
non-family based unrelated cohort. Nevertheless, our
comprehensive analysis suggested that they are potentially
important in bone metabolism.
In summary, we replicated a QTL on chromosome 5q21-
22 that inﬂuences femoral neck BMD in HKSC. Through
association analysis of 18 genes in this region, we identi-
ﬁed signiﬁcant association between CAST and ERAP1 with
Hum Genet (2011) 130:539–546 545
123femoral neck BMD variation. Future replication of these
candidate genes will be required to validate our ﬁndings,
while resequencing will be useful to better determine
whether common and/or rare genetic variation within these
two genes is associated with BMD variation.
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